ITIH2 as A Potential Drug Target for Cancer and Neurodegenerative Diseases

Target Name: ITIH2

NCBI ID: G3698

ITIH2

ITIH2 as A Potential Drug Target for Cancer and Neurodegenerative Diseases

ITIH2 (Inter-alpha-trypsin inhibitor complex component II) is a protein that is expressed in various tissues and cells in the human body. Its primary function is to regulate the activity of trypsin, an enzyme that is involved in the breakdown of cellular structures such as cytoskeletal filaments. In recent years, ITIH2 has gained significant interest as a potential drug target or biomarker due to its unique mechanism of action and its involvement in various diseases.

Diseases associated with ITIH2

ITIH2 is involved in various physiological processes in the body, including the regulation of cell division, differentiation, and signaling pathways. Its functions have been implicated in the development and progression of various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders.

One of the most significant associations with ITIH2 is its involvement in cancer. Many studies have shown that high levels of ITIH2 are associated with the development and progression of various types of cancer, including breast, ovarian, and prostate cancers. This is because ITIH2 has has been shown to promote the growth and survival of cancer cells, and it has been identified as a potential therapeutic target in cancer treatment.

Another potential application of ITIH2 as a drug target is its role in neurodegenerative diseases. ITIH2 has been shown to contribute to the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. This is because ITIH2 has been shown to promote the breakdown of protective cellular structures, such as the myelin sheath in neurodegenerative diseases, which can lead to the progression of these diseases.

ITIH2's role in autoimmune disorders has also been increasingly recognized. Many studies have shown that ITIH2 is involved in the development and maintenance of autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis. This is because ITIH2 has been shown to promote the production and activation of immune cells, which can contribute to the development of autoimmune disorders.

Mechanism of action

The mechanism of action of ITIH2 is complex and still being studied. However, it is known that ITIH2 functions by inhibiting the activity of trypsin, an enzyme that is involved in the breakdown of cellular structures. This inhibition of trypsin leads to the accumulation of damaged cellular structures, such as the myelin sheath in neurodegenerative diseases, or the cytoskeleton in cancer cells.

ITIH2 achieves its inhibitory effect by forming a complex with trypsin, which consists of ITIH2 and a regulatory protein called alpha-actinin. This complex inhibits the activity of trypsin and prevents it from breaking down cellular structures. This inhibition of trypsin allows ITIH2 to accumulate in damaged cells and contribute to the development and progression of various diseases.

ITIH2 has also been shown to regulate the activity of other enzymes involved in cellular processes, including the production of matrix metalloprotein (MMP) and the degradation of beta-tubulin. These enzymes are involved in the regulation of cell division, differentiation, and signaling pathways , and their regulation by ITIH2 has been implicated in the development and progression of various diseases.

Targeting ITIH2

ITIH2 is a potential drug target or biomarker due to its unique mechanism of action and its involvement in various diseases. Many studies have shown that blocking ITIH2 with small molecules or antibodies can lead to the inhibition of its activity and the regression of various diseases.

One of the most effective ways to target IT

Protein Name: Inter-alpha-trypsin Inhibitor Heavy Chain 2

Functions: May act as a carrier of hyaluronan in serum or as a binding protein between hyaluronan and other matrix protein, including those on cell surfaces in tissues to regulate the localization, synthesis and degradation of hyaluronan which are essential to cells undergoing biological processes

The "ITIH2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ITIH2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets